NCT05559775 2022-09-29A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard TherapyZhejiang Cancer HospitalPhase 2 Unknown20 enrolled